These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3153169

  • 21. Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.
    Vidalin O, Fournillier A, Renard N, Chen M, Depla E, Boucreux D, Brinster C, Baumert T, Nakano I, Fukuda Y, Liljeström P, Trépo C, Inchauspé G.
    Virology; 2000 Oct 25; 276(2):259-70. PubMed ID: 11040118
    [Abstract] [Full Text] [Related]

  • 22. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG, Kadoshnikov YP, Kalinina TI, Smirnov VD, Wahren B.
    Biochemistry (Mosc); 1998 May 25; 63(5):551-8. PubMed ID: 9632891
    [Abstract] [Full Text] [Related]

  • 23. Prospects for new viral vaccines.
    Norrby E.
    Microbiol Sci; 1987 Jul 25; 4(7):202-5. PubMed ID: 3153612
    [Abstract] [Full Text] [Related]

  • 24. Subunit, recombinant and synthetic hepatitis B vaccines.
    Zuckerman AJ.
    Microbiol Sci; 1985 May 25; 2(5):129-30, 133-8. PubMed ID: 2978963
    [Abstract] [Full Text] [Related]

  • 25. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection.
    Livingston BD, Crimi C, Grey H, Ishioka G, Chisari FV, Fikes J, Grey H, Chesnut RW, Sette A.
    J Immunol; 1997 Aug 01; 159(3):1383-92. PubMed ID: 9233635
    [Abstract] [Full Text] [Related]

  • 26. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
    Yue Q, Hu X, Yin W, Xu X, Wei S, Lei Y, Lü X, Yang J, Su M, Xu Z, Hao X.
    J Virol Methods; 2007 Apr 01; 141(1):41-8. PubMed ID: 17197041
    [Abstract] [Full Text] [Related]

  • 27. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA, Delgado CA, Estévez ZC, Martínez JC, Ríos GV, Aureoles-Roselló SR, Zaldívar RA, Guzmán MA, Baile NF, Reyes PA, Ruano LO, Fernández AC, Lobaina-Matos Y, Fernández AD, Madrazo AI, Martínez MI, Baños ML, Alvarez NP, Baldo MD, Mestre RE, Pérez MV, Martínez ME, Escobar DA, Guanche MJ, Cáceres LM, Betancourt RS, Rando EH, Nieto GE, González VL, Rubido JC.
    Int J Infect Dis; 2007 Sep 01; 11(5):394-401. PubMed ID: 17257877
    [Abstract] [Full Text] [Related]

  • 28. Hepatitis B: nature of the virus and prospects for vaccine development.
    Zuckerman AJ.
    Prog Liver Dis; 1976 Sep 01; 5():326-36. PubMed ID: 775545
    [No Abstract] [Full Text] [Related]

  • 29. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
    Xing Y, Huang Z, Lin Y, Li J, Chou TH, Lu S, Wang S.
    Vaccine; 2008 Sep 19; 26(40):5145-52. PubMed ID: 18462847
    [Abstract] [Full Text] [Related]

  • 30. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F, Loggi E, Chisholm JV, Biselli M, Morelli MC, Cursaro C, Terrault NA, Bernardi M, Bertoletti A, Andreone P, Brander C.
    Liver Transpl; 2008 Apr 19; 14(4):478-85. PubMed ID: 18324666
    [Abstract] [Full Text] [Related]

  • 31. Hepatitis B vaccination.
    Fagan EA, Williams R.
    Br J Clin Pract; 1987 Jan 19; 41(1):569-76. PubMed ID: 2959306
    [No Abstract] [Full Text] [Related]

  • 32. [Active and passive immunization against hepatitis B virus infection].
    Colak H.
    Mikrobiyol Bul; 1982 Jan 19; 16(1):71-6. PubMed ID: 7144619
    [Abstract] [Full Text] [Related]

  • 33. Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results.
    Berthelot P, Courouce AM, Eyquem A, Feldmann G, Jacob J, Ravisse P, Vacher B, Moor-Jankowski J, Muchmore E, Prince A.
    J Med Primatol; 1984 Jan 19; 13(3):119-33. PubMed ID: 6239039
    [Abstract] [Full Text] [Related]

  • 34. Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus.
    Ogata N, Cote PJ, Zanetti AR, Miller RH, Shapiro M, Gerin J, Purcell RH.
    Hepatology; 1999 Sep 19; 30(3):779-86. PubMed ID: 10462386
    [Abstract] [Full Text] [Related]

  • 35. Adenovirus vectored vaccines.
    Natuk RJ, Davis AR, Chanda PK, Lubeck MD, Chengalvala M, Murthy SC, Wade MS, Dheer SK, Bhat BM, Murthy KK.
    Dev Biol Stand; 1994 Sep 19; 82():71-7. PubMed ID: 7958485
    [Abstract] [Full Text] [Related]

  • 36. [Hepatitis B virus. Application of recombinant DNA technics to the development of hepatitis B vaccines and its diagnosis].
    Hamada F.
    Rinsho Byori; 1988 May 19; 36(5):548-52. PubMed ID: 2971829
    [No Abstract] [Full Text] [Related]

  • 37. [Hepatitis B vaccination in a large chemical plant].
    Urbatus W.
    Ther Umsch; 1985 Sep 19; 42(9):608-10. PubMed ID: 4071449
    [No Abstract] [Full Text] [Related]

  • 38. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
    Riedl P, Wieland A, Lamberth K, Buus S, Lemonnier F, Reifenberg K, Reimann J, Schirmbeck R.
    J Immunol; 2009 Jul 01; 183(1):370-80. PubMed ID: 19542448
    [Abstract] [Full Text] [Related]

  • 39. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
    Rendi-Wagner P, Wiedermann G, Stemberger H, Kollaritsch H.
    Wien Klin Wochenschr; 2002 Mar 28; 114(5-6):175-80. PubMed ID: 12238305
    [Abstract] [Full Text] [Related]

  • 40. [Immune response to the vaccine (Hepavax B) against the B virus].
    Pérez V, Fay O.
    Acta Gastroenterol Latinoam; 1983 Mar 28; 13(4):675-82. PubMed ID: 6680259
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.